The average length of stay for carcinoma in situ in France has remained stable at 3.2 days from 2024 through 2027, with a slight decrease to 3.1 days in 2028. Compared to 2023, this data suggests a steady trend with a minimal year-on-year reduction towards 2028.
Future trends to watch for include the potential impacts of medical advancements and policy changes that could further reduce the length of stay. Also, monitoring shifts in healthcare practices and technologies might reveal opportunities for enhanced outpatient care and reduced hospitalization time.
